General Information of Drug (ID: DM2IXO0)

Drug Name
3-[5-(4-hydroxyphenyl)-1,3-thiazol-2-yl]phenol
Synonyms SCHEMBL1180532; CHEMBL458727; BDBM25831; WBUPCNHALRFMCB-UHFFFAOYSA-N; hydroxyphenyl substituted thiazole, 3; 3-[5-(4-Hydroxyphenyl)-1,3-thiazole-2-yl]phenol
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 269.3
Logarithm of the Partition Coefficient (xlogp) 3.6
Rotatable Bond Count (rotbonds) 2
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 4
Chemical Identifiers
Formula
C15H11NO2S
IUPAC Name
3-[5-(4-hydroxyphenyl)-1,3-thiazol-2-yl]phenol
Canonical SMILES
C1=CC(=CC(=C1)O)C2=NC=C(S2)C3=CC=C(C=C3)O
InChI
InChI=1S/C15H11NO2S/c17-12-6-4-10(5-7-12)14-9-16-15(19-14)11-2-1-3-13(18)8-11/h1-9,17-18H
InChIKey
WBUPCNHALRFMCB-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
25093373
TTD ID
D00SLE

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) TTIWB6L DHB1_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 New insights into the SAR and binding modes of bis(hydroxyphenyl)thiophenes and -benzenes: influence of additional substituents on 17beta-hydroxyst... J Med Chem. 2009 Nov 12;52(21):6724-43.